Con:Antitrustchallenges🌎ID&E:May reduceequitableaccess ifcosts rise❌Con:ReducescompetitionCon: Riskof marketmonopolyCon:Raisescost forconsumers✅Pro:Encouragesefficiency“Antitrust”🌎ID&E:Risk of biasintechnologyadoption✅Pro:Improvespatientoutcomes❌Con:StiflessmallercompetitorsJenaValvePro:Encouragesefficiency✅Pro:Createscompetitiveadvantage✅Pro:DrivesinnovationID&E:Opportunityto designfor inclusion“Innovation”❌Con: Canlimitinnovation (ifmonopolized)Pro:Expandstreatmentoptions❌Con:AntitrustchallengesCon:Reducescompetition❌Con:Risk ofmarketmonopolyPro:Improvespatientoutcomes🌎ID&E:Increasesaccess tolife-savingdevicesID&E:Increasesaccess tolife-savingdevices❌Con:Raisescost forconsumersID&E: Mayreduceequitableaccess ifcosts riseID&E:Regulatoryoversightprotectsfairness✅Pro:Expandstreatmentoptions🌎ID&E:Opportunityto designfor inclusionCon:Potential jobloss insmaller firms✅Pro:PromotesfasterdevelopmentPro:Createscompetitiveadvantage✅Pro:Lowerslong-termcosts🌎ID&E:Impactsaffordability forunderservedpopulations❌Con:Potential jobloss insmaller firmsID&E: Couldcreateglobaldisparities“Antitrust”🌎ID&E:RegulatoryoversightprotectsfairnessPro:PromotesfasterdevelopmentThoratecPro:Lowerslong-termcosts“CaseStudyMentioned”🌎ID&E:Could createglobaldisparities“CaseStudyMentioned”TAVR-ARdeviceCon: StiflessmallercompetitorsID&E: Riskof bias intechnologyadoptionCon: Canlimitinnovation (ifmonopolized)ID&E:ImpactsaffordabilityforunderservedpopulationsEdwardsLifesciencesHeartWarePro:Drivesinnovation“Innovation”Con:Antitrustchallenges🌎ID&E:May reduceequitableaccess ifcosts rise❌Con:ReducescompetitionCon: Riskof marketmonopolyCon:Raisescost forconsumers✅Pro:Encouragesefficiency“Antitrust”🌎ID&E:Risk of biasintechnologyadoption✅Pro:Improvespatientoutcomes❌Con:StiflessmallercompetitorsJenaValvePro:Encouragesefficiency✅Pro:Createscompetitiveadvantage✅Pro:DrivesinnovationID&E:Opportunityto designfor inclusion“Innovation”❌Con: Canlimitinnovation (ifmonopolized)Pro:Expandstreatmentoptions❌Con:AntitrustchallengesCon:Reducescompetition❌Con:Risk ofmarketmonopolyPro:Improvespatientoutcomes🌎ID&E:Increasesaccess tolife-savingdevicesID&E:Increasesaccess tolife-savingdevices❌Con:Raisescost forconsumersID&E: Mayreduceequitableaccess ifcosts riseID&E:Regulatoryoversightprotectsfairness✅Pro:Expandstreatmentoptions🌎ID&E:Opportunityto designfor inclusionCon:Potential jobloss insmaller firms✅Pro:PromotesfasterdevelopmentPro:Createscompetitiveadvantage✅Pro:Lowerslong-termcosts🌎ID&E:Impactsaffordability forunderservedpopulations❌Con:Potential jobloss insmaller firmsID&E: Couldcreateglobaldisparities“Antitrust”🌎ID&E:RegulatoryoversightprotectsfairnessPro:PromotesfasterdevelopmentThoratecPro:Lowerslong-termcosts“CaseStudyMentioned”🌎ID&E:Could createglobaldisparities“CaseStudyMentioned”TAVR-ARdeviceCon: StiflessmallercompetitorsID&E: Riskof bias intechnologyadoptionCon: Canlimitinnovation (ifmonopolized)ID&E:ImpactsaffordabilityforunderservedpopulationsEdwardsLifesciencesHeartWarePro:Drivesinnovation“Innovation”

Competitive Technology - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
  1. Con: Antitrust challenges
  2. 🌎ID&E: May reduce equitable access if costs rise
  3. ❌Con: Reduces competition
  4. Con: Risk of market monopoly
  5. Con: Raises cost for consumers
  6. ✅Pro: Encourages efficiency
  7. “Antitrust”
  8. 🌎ID&E: Risk of bias in technology adoption
  9. ✅Pro: Improves patient outcomes
  10. ❌Con: Stifles smaller competitors
  11. JenaValve
  12. Pro: Encourages efficiency
  13. ✅Pro: Creates competitive advantage
  14. ✅Pro: Drives innovation
  15. ID&E: Opportunity to design for inclusion
  16. “Innovation”
  17. ❌Con: Can limit innovation (if monopolized)
  18. Pro: Expands treatment options
  19. ❌Con: Antitrust challenges
  20. Con: Reduces competition
  21. ❌Con: Risk of market monopoly
  22. Pro: Improves patient outcomes
  23. 🌎ID&E: Increases access to life-saving devices
  24. ID&E: Increases access to life-saving devices
  25. ❌Con: Raises cost for consumers
  26. ID&E: May reduce equitable access if costs rise
  27. ID&E: Regulatory oversight protects fairness
  28. ✅Pro: Expands treatment options
  29. 🌎ID&E: Opportunity to design for inclusion
  30. Con: Potential job loss in smaller firms
  31. ✅Pro: Promotes faster development
  32. Pro: Creates competitive advantage
  33. ✅Pro: Lowers long-term costs
  34. 🌎ID&E:Impacts affordability for underserved populations
  35. ❌Con: Potential job loss in smaller firms
  36. ID&E: Could create global disparities
  37. “Antitrust”
  38. 🌎ID&E: Regulatory oversight protects fairness
  39. Pro: Promotes faster development
  40. Thoratec
  41. Pro: Lowers long-term costs
  42. “Case Study Mentioned”
  43. 🌎ID&E: Could create global disparities
  44. “Case Study Mentioned”
  45. TAVR-AR device
  46. Con: Stifles smaller competitors
  47. ID&E: Risk of bias in technology adoption
  48. Con: Can limit innovation (if monopolized)
  49. ID&E:Impacts affordability for underserved populations
  50. Edwards Lifesciences
  51. HeartWare
  52. Pro: Drives innovation
  53. “Innovation”